Lord, Abbett & Co’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-242,580
Closed -$5.02M 535
2024
Q1
$5.02M Sell
242,580
-128,407
-35% -$2.65M 0.02% 474
2023
Q4
$8.57M Buy
+370,987
New +$8.57M 0.03% 402